Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This is an open-label, 2-arm study in which patients are randomized to receive either the formulation that is being used in clinical trials or the formulation that will be used when if the drug becomes commercially available. The purpose of this study is to compare the pharmacokinetics of the two formulations.
Epistemonikos ID: 3bae1f222c245848ed2a281346a9e9b4adda14f8
First added on: May 04, 2024